National Cancer Institute / Children’s Hospital / Women’s Hospital / Massachusetts General Hospital / Clinical Trials Dana-Farber/Harvard Cancer Center Dana-Farber Cancer Institute / Reilly Families Cell Manipulation Core Facility / Dana-Farber Cancer Institute / Beth Israel Deaconess Medical Center / / /
IndustryTerm
clinical trials infrastructure / online system / similar protocols / /
MedicalCondition
DF / consortium type cancer / primary disease / Cancer / disease / /
Organization
office of Human Research Protection / DHHS Office for Human Research Protections / National Cancer Institute / Safety Monitoring Board / Trials Operations Committee / Harvard Cancer Center / Coordinating Committee / Food and Drug Administration / Division of Hematology/Oncology / Multi-Center Coordinating Committee / office of Human Research Studies / International Rugby Board / HARVARD / Scientific Review Committee / Progress Review Committee / MPH CCRP Deputy Director Quality Assurance Office / IRB / DFCI Institutional Review Board / Audit Committee / Beth Israel Deaconess Medical Center / Clinical Investigations Leadership Committee / Women’s Hospital / Massachusetts General Hospital / Children’s Hospital Boston / Clinical Trials Dana-Farber/Harvard Cancer Center Dana-Farber Cancer Institute / DF/HCC Center / Department of Health and Human Services / Investigations and Leadership Committee / Dana-Farber Cancer Institute / Safety Monitoring Committee / HCC SRC / Department of Pediatric Oncology / / /
Position
Attorney / team member / Ad Hoc Consultant / PSRC Chair / Deputy Director / NCI Grant Program Director / Director / chairperson / Chair / Director Responsible / representative / Continuing Consultant / General Counsel / Senior Vice President for Research and Institutional Official/DF/HCC Associate Director for Administration / SRC Chairperson / Legal Counsel / Director / OHRS Deputy / /
Dana-Farber / Harvard Cancer Center Institutional Data and Safety Monitoring Plan